Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenqin Yue

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Experimental and Therapeutic Medicine|November 7, 2017
Artemether suppresses cell proliferation and induces apoptosis in diffuse large B cell lymphoma cellsXinying Zhao, Xudong Guo, Wenqin Yue, et al.
Materials (Basel, Switzerland)|November 14, 2023
Nanostructure Effect on Magnetization Processes in FePt Polytwin CrystalsJingwei Yi, Xinyu Xu, Wenqin Yue, et al.
Cell Death & Disease|January 21, 2018
HBV infection potentiates resistance to S-phase arrest-inducing chemotherapeutics by inhibiting CHK2 pathway in diffuse large B-cell lymphomaXinying Zhao, Xudong Guo, Libo Xing, et al.
Blood Cancer Journal|March 15, 2024
In vivo expression of anti-CD19/CD3 BiTE by liver-targeted AAV for the treatment of B cell malignanciesZhiqiang Song, Ping Liu, Dongliang Zhang, et al.
BMC Medical Education|November 28, 2025
Application of scenario simulation based on boppps model in physical diagnostics--a practical exploration of integrated teaching mode for cardiac physical examination and electrocardiogramBingshu Wu, Tianran Chen, Xiaobin Mei, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 15, 2018
The pretreatment albumin to globulin ratio as a significant predictor in patients with diffuse large B cell lymphomaWenqin Yue, Bin Liu, Lei Gao, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 13, 2018
Prognostic value of pretreatment plasma D-dimer levels in patients with diffuse large B cell lymphoma (DLBCL)Bin Liu, Bo Li, Pingting Zhou, et al.
Frontiers in Oncology|January 3, 2022
<i>SAMHD1</i> Mutations and Expression in Mantle Cell Lymphoma PatientsTao Wang, Wenqin Yue, Gusheng Tang, et al.
Immunotherapy|August 6, 2020
Hematopoietic stem cell transplantation and chimeric antigen receptor T cell for relapsed or refractory diffuse large B-cell lymphomaTao Wang, Lei Gao, Yujie Wang, et al.
Hematological Oncology|February 10, 2022
Chimeric antigen receptor T-cell therapy combined with autologous stem cell transplantation improved progression-free survival of relapsed or refractory diffuse large B-cell lymphoma patients: A single-center, retrospective, cohort studyTao Wang, Lili Xu, Lei Gao, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Experimental and Therapeutic Medicine|November 7, 2017
Artemether suppresses cell proliferation and induces apoptosis in diffuse large B cell lymphoma cellsXinying Zhao, Xudong Guo, Wenqin Yue, et al.
Materials (Basel, Switzerland)|November 14, 2023
Nanostructure Effect on Magnetization Processes in FePt Polytwin CrystalsJingwei Yi, Xinyu Xu, Wenqin Yue, et al.
Cell Death & Disease|January 21, 2018
HBV infection potentiates resistance to S-phase arrest-inducing chemotherapeutics by inhibiting CHK2 pathway in diffuse large B-cell lymphomaXinying Zhao, Xudong Guo, Libo Xing, et al.
Blood Cancer Journal|March 15, 2024
In vivo expression of anti-CD19/CD3 BiTE by liver-targeted AAV for the treatment of B cell malignanciesZhiqiang Song, Ping Liu, Dongliang Zhang, et al.
BMC Medical Education|November 28, 2025
Application of scenario simulation based on boppps model in physical diagnostics--a practical exploration of integrated teaching mode for cardiac physical examination and electrocardiogramBingshu Wu, Tianran Chen, Xiaobin Mei, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 15, 2018
The pretreatment albumin to globulin ratio as a significant predictor in patients with diffuse large B cell lymphomaWenqin Yue, Bin Liu, Lei Gao, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 13, 2018
Prognostic value of pretreatment plasma D-dimer levels in patients with diffuse large B cell lymphoma (DLBCL)Bin Liu, Bo Li, Pingting Zhou, et al.
Frontiers in Oncology|January 3, 2022
<i>SAMHD1</i> Mutations and Expression in Mantle Cell Lymphoma PatientsTao Wang, Wenqin Yue, Gusheng Tang, et al.
Immunotherapy|August 6, 2020
Hematopoietic stem cell transplantation and chimeric antigen receptor T cell for relapsed or refractory diffuse large B-cell lymphomaTao Wang, Lei Gao, Yujie Wang, et al.
Hematological Oncology|February 10, 2022
Chimeric antigen receptor T-cell therapy combined with autologous stem cell transplantation improved progression-free survival of relapsed or refractory diffuse large B-cell lymphoma patients: A single-center, retrospective, cohort studyTao Wang, Lili Xu, Lei Gao, et al.
Pageof 2